These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35385330)

  • 1. Boswellia serrata extract shows cognitive benefits in a double-blind, randomized, placebo-controlled pilot clinical trial in individuals who suffered traumatic brain injury.
    Meshkat S; Mahmoodi Baram S; Rajaei S; Mohammadian F; Kouhestani E; Amirzargar N; Tafakhori A; Shafiee S; Meshkat M; Balenci L; Kiss A; Riazi A; Salimi A; Aghamollaii V; Salmani F; Karima S
    Brain Inj; 2022 Mar; 36(4):553-559. PubMed ID: 35385330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial.
    Theadom A; Barker-Collo S; Jones KM; Parmar P; Bhattacharjee R; Feigin VL
    Eur J Neurol; 2018 Aug; 25(8):1055-e82. PubMed ID: 29611892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traumatic hemorrhagic brain injury: impact of location and resorption on cognitive outcome.
    Martin RM; Wright MJ; Lutkenhoff ES; Ellingson BM; Van Horn JD; Tubi M; Alger JR; McArthur DL; Vespa PM
    J Neurosurg; 2017 Mar; 126(3):796-804. PubMed ID: 27231979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K
    Phytother Res; 2019 May; 33(5):1457-1468. PubMed ID: 30838706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, double-blind pilot trial.
    Kirste S; Treier M; Wehrle SJ; Becker G; Abdel-Tawab M; Gerbeth K; Hug MJ; Lubrich B; Grosu AL; Momm F
    Cancer; 2011 Aug; 117(16):3788-95. PubMed ID: 21287538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for Safety and Efficacy of MLC901 (NeuroAiD II) in Patients With Moderate Traumatic Brain Injury: A Randomized Double-Blind Placebo-Controlled Trial (ANDROMEDA).
    Chua AE; Yacapin VJ; Manalo GL; Ledesma LK
    Neurosurgery; 2023 Oct; 93(4):939-951. PubMed ID: 37129384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double blind, placebo controlled, cross over study to evaluate the analgesic activity of Boswellia serrata in healthy volunteers using mechanical pain model.
    Prabhavathi K; Chandra US; Soanker R; Rani PU
    Indian J Pharmacol; 2014; 46(5):475-9. PubMed ID: 25298573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Reserve and Age Predict Cognitive Recovery after Mild to Severe Traumatic Brain Injury.
    Fraser EE; Downing MG; Biernacki K; McKenzie DP; Ponsford JL
    J Neurotrauma; 2019 Oct; 36(19):2753-2761. PubMed ID: 31017049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine Did Not Positively Impact Cognition in Chronic Traumatic Brain Injury: A Multi-Site, Randomized, Controlled Trial.
    Hammond FM; Sherer M; Malec JF; Zafonte RD; Dikmen S; Bogner J; Bell KR; Barber J; Temkin N
    J Neurotrauma; 2018 Oct; 35(19):2298-2305. PubMed ID: 29742960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial.
    McDonald BC; Flashman LA; Arciniegas DB; Ferguson RJ; Xing L; Harezlak J; Sprehn GC; Hammond FM; Maerlender AC; Kruck CL; Gillock KL; Frey K; Wall RN; Saykin AJ; McAllister TW
    Neuropsychopharmacology; 2017 Aug; 42(9):1766-1775. PubMed ID: 27874023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial.
    Brawman-Mintzer O; Tang XC; Bizien M; Harvey PD; Horner MD; Arciniegas DB; Raskind M; Johnson-Greene L; Martineau RJ; Hamner M; Rodriguez-Suarez M; Jorge RE; McGarity S; Wortzel HS; Wei Y; Sindowski T; Mintzer J; Kindy AZ; Donovan K; Reda D
    J Neurotrauma; 2021 Jul; 38(14):1943-1952. PubMed ID: 33514274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.
    Rowell SE; Meier EN; McKnight B; Kannas D; May S; Sheehan K; Bulger EM; Idris AH; Christenson J; Morrison LJ; Frascone RJ; Bosarge PL; Colella MR; Johannigman J; Cotton BA; Callum J; McMullan J; Dries DJ; Tibbs B; Richmond NJ; Weisfeldt ML; Tallon JM; Garrett JS; Zielinski MD; Aufderheide TP; Gandhi RR; Schlamp R; Robinson BRH; Jui J; Klein L; Rizoli S; Gamber M; Fleming M; Hwang J; Vincent LE; Williams C; Hendrickson A; Simonson R; Klotz P; Sopko G; Witham W; Ferrara M; Schreiber MA
    JAMA; 2020 Sep; 324(10):961-974. PubMed ID: 32897344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of tablet containing Boswellia serrata and Melisa officinalis extract on older adults' memory: A randomized controlled trial.
    Taghizadeh M; Maghaminejad F; Aghajani M; Rahmani M; Mahboubi M
    Arch Gerontol Geriatr; 2018; 75():146-150. PubMed ID: 29306113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huperzine A for the treatment of cognitive, mood, and functional deficits after moderate and severe TBI (HUP-TBI): results of a Phase II randomized controlled pilot study: implications for understanding the placebo effect.
    Zafonte RD; Fregni F; Bergin MJG; Goldstein R; Boudreau N; Monge I; Luz M; Frazier J; Giacino JT
    Brain Inj; 2020; 34(1):34-41. PubMed ID: 31638455
    [No Abstract]   [Full Text] [Related]  

  • 15. Repetitive TMS does not improve cognition in patients with TBI: A randomized double-blind trial.
    Neville IS; Zaninotto AL; Hayashi CY; Rodrigues PA; Galhardoni R; Ciampi de Andrade D; Brunoni AR; Amorim RLO; Teixeira MJ; Paiva WS
    Neurology; 2019 Jul; 93(2):e190-e199. PubMed ID: 31175209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A
    J Alzheimers Dis; 2023; 94(1):359-370. PubMed ID: 37248896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Placebo-Controlled Trial of Methylphenidate or Galantamine for Persistent Emotional and Cognitive Symptoms Associated with PTSD and/or Traumatic Brain Injury.
    McAllister TW; Zafonte R; Jain S; Flashman LA; George MS; Grant GA; He F; Lohr JB; Andaluz N; Summerall L; Paulus MP; Raman R; Stein MB
    Neuropsychopharmacology; 2016 Apr; 41(5):1191-8. PubMed ID: 26361060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind trial of solid lipid Boswellia serrata particles (SLBSP) vs. standardized Boswellia serrata gum extract (BSE) for osteoarthritis of knee.
    Kulkarni PD; Damle ND; Singh S; Yadav KS; Ghante MR; Bhaskar VH; Hingorani L; Gota VS
    Drug Metab Pers Ther; 2020 Jun; 35(2):. PubMed ID: 32549135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
    Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W
    Inflamm Bowel Dis; 2011 Feb; 17(2):573-82. PubMed ID: 20848527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does cognitive decline occur decades after moderate to severe traumatic brain injury? A prospective controlled study.
    Hicks AJ; Spitz G; Rowe CC; Roberts CM; McKenzie DP; Ponsford JL
    Neuropsychol Rehabil; 2022 Aug; 32(7):1530-1549. PubMed ID: 33858304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.